These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 12784537)

  • 1. [Nicastrin--a protein with a hinge function].
    Giessen H
    Pharm Unserer Zeit; 2003; 32(3):180-1. PubMed ID: 12784537
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nicastrin].
    Nishimura M
    Nihon Rinsho; 2011 Oct; 69 Suppl 8():115-8. PubMed ID: 22787765
    [No Abstract]   [Full Text] [Related]  

  • 3. Excess of nicastrin in brain results in heterozygosity having no effect on endogenous APP processing and amyloid peptide levels in vivo.
    Brijbassi S; Amtul Z; Newbigging S; Westaway D; St George-Hyslop P; Rozmahel RF
    Neurobiol Dis; 2007 Feb; 25(2):291-6. PubMed ID: 17071095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wild-type and mutated nicastrins do not display aminopeptidase M- and B-like activities.
    Fergani A; Yu G; St George-Hyslop P; Checler F
    Biochem Biophys Res Commun; 2001 Dec; 289(3):678-80. PubMed ID: 11726200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel alternative splice variant of nicastrin and its implication in Alzheimer disease.
    Mitsuda N; Yamagata HD; Zhong W; Aoto M; Akatsu H; Uekawa N; Kamino K; Taguchi K; Yamamoto T; Maruyama M; Kosaka K; Takeda M; Kondo I; Miki T
    Life Sci; 2006 Apr; 78(21):2444-8. PubMed ID: 16303145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification and clone of human Alzheimer's disease related gene nicastrin promoter].
    Yang M; Cai F; Wang RS; Pan Q; Long ZG; Deng XY; Xia K; Xia JH; Zhang ZH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):9-13. PubMed ID: 16562666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicastrin: gatekeeper of the gamma-secretase complex.
    De Strooper B
    Cell; 2005 Aug; 122(3):318-20. PubMed ID: 16096051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neprilysin activity and expression are controlled by nicastrin.
    Pardossi-Piquard R; Dunys J; Yu G; St George-Hyslop P; Alves da Costa C; Checler F
    J Neurochem; 2006 May; 97(4):1052-6. PubMed ID: 16606360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alzheimer's disease: focus on beta-amyloid and gamma-secretase].
    Iwatsubo T
    Tanpakushitsu Kakusan Koso; 2004 May; 49(7 Suppl):1086-90. PubMed ID: 15168534
    [No Abstract]   [Full Text] [Related]  

  • 10. Nicastrin functions as a gamma-secretase-substrate receptor.
    Shah S; Lee SF; Tabuchi K; Hao YH; Yu C; LaPlant Q; Ball H; Dann CE; Südhof T; Yu G
    Cell; 2005 Aug; 122(3):435-47. PubMed ID: 16096062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular localization of Nicastrin affects amyloid beta species production.
    Morais VA; Leight S; Pijak DS; Lee VM; Costa J
    FEBS Lett; 2008 Feb; 582(3):427-33. PubMed ID: 18201567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicastrin expression in mouse peripheral tissues is not co-ordinated with presenilin and is high in muscle.
    Ilaya NT; Evin G; Masters CL; Culvenor JG
    J Neurochem; 2004 Oct; 91(1):230-7. PubMed ID: 15379903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat nicastrin gene: cDNA isolation, mRNA variants and expression pattern analysis.
    Confaloni A; Crestini A; Albani D; Piscopo P; Campeggi LM; Terreni L; Tartaglia M; Forloni G
    Brain Res Mol Brain Res; 2005 May; 136(1-2):12-22. PubMed ID: 15893582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid-beta precursor protein processing in neurodegeneration.
    Wilquet V; De Strooper B
    Curr Opin Neurobiol; 2004 Oct; 14(5):582-8. PubMed ID: 15464891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenesis of Alzheimer's disease: implications from amyloid research front].
    Iwatsubo T
    Rinsho Shinkeigaku; 2004 Nov; 44(11):768-70. PubMed ID: 15651286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic mechanisms in Alzheimer's disease.
    Pastorino L; Lu KP
    Eur J Pharmacol; 2006 Sep; 545(1):29-38. PubMed ID: 16904664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular pathology and therapeutics in Alzheimer's disease: amyloid beta-protein as a therapeutic target].
    Ohyagi Y
    Fukuoka Igaku Zasshi; 2006 Sep; 97(9):261-8. PubMed ID: 17134029
    [No Abstract]   [Full Text] [Related]  

  • 18. Identity and function of gamma-secretase.
    Kimberly WT; Wolfe MS
    J Neurosci Res; 2003 Nov; 74(3):353-60. PubMed ID: 14598311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer disease: BACE1 branches out.
    Schubert C
    Nat Med; 2006 Oct; 12(10):1123. PubMed ID: 17024203
    [No Abstract]   [Full Text] [Related]  

  • 20. Secretase inhibitors and modulators for Alzheimer's disease treatment.
    Tomita T
    Expert Rev Neurother; 2009 May; 9(5):661-79. PubMed ID: 19402777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.